Assignee
OVID THERAPEUTICS INC
US·51 granted patents·76 pending applications·246 citations·filing 2015–2025
Top patents by PatentIndex Score
127 records- 0199US11395817B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Jul 26, 2022·8 cites·31 claims
- 0299US10799485B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Oct 13, 2020·8 cites·20 claims
- 0399US10603308B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Mar 31, 2020·17 cites·13 claims
- 0499US9446028B2Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2016·26 cites·8 claims
- 0598US9682069B2Methods of treating Dravet syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·19 cites·7 claims
- 0698US9351968B1Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2015·Granted May 31, 2016·24 cites·4 claims
- 0798US9339495B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·26 cites·6 claims
- 0897US10363246B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Jul 30, 2019·13 cites·5 claims
- 0997US10071083B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Sep 11, 2018·11 cites·15 claims
- 1097US9801864B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·7 cites·6 claims
- 1197US9744159B2Methods of treatment Rett syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·9 cites·13 claims
- 1296US9717716B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2016·Granted Aug 1, 2017·16 cites·30 claims
- 1396US9399034B1Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2015·Granted Jul 26, 2016·20 cites·10 claims
- 1494US10188635B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·5 cites·15 claims
- 1594US9913833B2Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Mar 13, 2018·4 cites·4 claims
- 1693US11291658B2Use of gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·2 cites·16 claims
- 1793US10653652B2Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addictionOVID THERAPEUTICS INC·Filed 2019·Granted May 19, 2020·5 cites·7 claims
- 1893US2025025448A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1992US2024415817A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2092US2025025449A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2191US10813918B2Use of Gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2018·Granted Oct 27, 2020·3 cites·15 claims
- 2291US9610261B2Methods of treating Prader-Willi SyndromeOVID THERAPEUTICS INC·Filed 2016·Granted Apr 4, 2017·3 cites·10 claims
- 2390US11918563B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Mar 5, 2024·0 cites·16 claims
- 2489US11903930B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Feb 20, 2024·0 cites·20 claims
- 2589US11806336B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Nov 7, 2023·0 cites·41 claims
- 2689US11096929B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·3 cites·13 claims
- 2789US10195165B2Methods of treating Prader-Willi syndromeOVID THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·2 cites·10 claims
- 2887US10765646B2Methods of treating developmental encephalopathiesOVID THERAPEUTICS INC·Filed 2018·Granted Sep 8, 2020·2 cites·12 claims
- 2987US10111865B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2017·Granted Oct 30, 2018·2 cites·23 claims
- 3087US9827233B1Methods of treating behavioral syndromes using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Nov 28, 2017·4 cites·3 claims
- 3186US12144801B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·18 claims
- 3285US12465597B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2022·Granted Nov 11, 2025·0 cites·1 claims
- 3385US12109201B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·21 claims
- 3485US2023051859A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3584US10870855B2Use of MIR101 or MIR128 in the treatment of seizure disordersOVID THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·1 cites·19 claims
- 3684US10704048B2Use of MIR-92A or MIR-145 in the treatment of Angelman syndromeOVID THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·29 claims
- 3784US10420773B2Methods of treating developmental disorders and/or seizure disorders with etifoxineOVID THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·1 cites·8 claims
- 3884US2024173280A1Methods of treating seizure disorders and prader-willi syndromeOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3981US2024252447A1Pharmaceutical formulations containing gaboxadol for therapeutic treatmentOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4081US2022016091A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4181US2025073214A1Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4280US2021213000A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4379US10813899B2Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disordersOVID THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·2 cites·14 claims
- 4479US2023404955A1Use of (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere’s disease, tourette’s syndrome, attention deficit hyperactivity disorder and addictionOVID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4578US12285397B2Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disordersOVID THERAPEUTICS INC·Filed 2023·Granted Apr 29, 2025·0 cites·17 claims
- 4678US11918551B2Methods of treating seizure disorders and Prader-Willi syndromeOVID THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·0 cites·7 claims
- 4778US10765666B2Use of gaboxadol for the treatment of Tourette syndrome, tics and stutteringOVID THERAPEUTICS INC·Filed 2019·Granted Sep 8, 2020·1 cites·20 claims
- 4878US2023285369A1Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4977US11690829B2Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2019·Granted Jul 4, 2023·0 cites·11 claims
- 5077US2019255027A1Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 127 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →